1. Home
  2. BHB vs VERV Comparison

BHB vs VERV Comparison

Compare BHB & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHB
  • VERV
  • Stock Information
  • Founded
  • BHB 1887
  • VERV 2018
  • Country
  • BHB United States
  • VERV United States
  • Employees
  • BHB N/A
  • VERV N/A
  • Industry
  • BHB Major Banks
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • BHB Finance
  • VERV Health Care
  • Exchange
  • BHB Nasdaq
  • VERV Nasdaq
  • Market Cap
  • BHB 456.0M
  • VERV 384.2M
  • IPO Year
  • BHB 1997
  • VERV 2021
  • Fundamental
  • Price
  • BHB $29.31
  • VERV $11.21
  • Analyst Decision
  • BHB Hold
  • VERV Buy
  • Analyst Count
  • BHB 2
  • VERV 9
  • Target Price
  • BHB $33.00
  • VERV $14.75
  • AVG Volume (30 Days)
  • BHB 40.4K
  • VERV 8.0M
  • Earning Date
  • BHB 07-17-2025
  • VERV 08-07-2025
  • Dividend Yield
  • BHB 4.33%
  • VERV N/A
  • EPS Growth
  • BHB 3.26
  • VERV N/A
  • EPS
  • BHB 2.84
  • VERV N/A
  • Revenue
  • BHB $149,882,000.00
  • VERV $59,613,000.00
  • Revenue This Year
  • BHB $18.22
  • VERV $27.75
  • Revenue Next Year
  • BHB $13.38
  • VERV N/A
  • P/E Ratio
  • BHB $10.41
  • VERV N/A
  • Revenue Growth
  • BHB 2.29
  • VERV 271.44
  • 52 Week Low
  • BHB $24.65
  • VERV $2.87
  • 52 Week High
  • BHB $38.47
  • VERV $11.41
  • Technical
  • Relative Strength Index (RSI)
  • BHB 50.90
  • VERV 85.11
  • Support Level
  • BHB $28.39
  • VERV $11.04
  • Resistance Level
  • BHB $30.13
  • VERV $11.41
  • Average True Range (ATR)
  • BHB 0.64
  • VERV 0.40
  • MACD
  • BHB 0.05
  • VERV 0.53
  • Stochastic Oscillator
  • BHB 59.41
  • VERV 96.87

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Share on Social Networks: